Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Ear (auricular) vagus nerve stimulation to lower inflammation after long spinal fusion

Official title: Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

Run by Washington University School of Medicine · NCT07218133 · Data updated 2026-11-12

This trial will test whether non-invasive ear-based vagus nerve stimulation can lower inflammation, improve blood sugar control, and reduce pain after long-segment spinal fusion surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedOctober 8, 2025
Main results expectedJanuary 2027
Study endsJune 2027
Registry record updatedAugust 18, 2026
Trial IDNCT07218133 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults having long-segment spinal fusions (constructs spanning at least L2-pelvis for thoracolumbar or C2-T2 for cervical) who can undergo reliable neurologic exams and pain assessments are ideal candidates.

Probably not a fit

Patients with shorter-segment fusions, age under 18, active cancer therapy, immunosuppressive treatment, recent additional spinal surgery, pacemaker or sustained bradycardia, or a history of substance abuse are unlikely to be eligible or receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled trial comparing non-invasive trans-auricular vagus nerve stimulation versus a sham procedure in patients undergoing long-segment spinal fusion. Participants will receive perioperative auricular stimulation and researchers will monitor inflammatory markers (including cytokines), glycemic control, pain scores, and inflammation-related clinical outcomes such as wound complications and readmissions. The study focuses on extensive open fusion constructs (L2-pelvis or C2-T2) that generate large systemic inflammatory responses. Outcomes will be collected in the immediate postoperative period to determine whether this non-pharmacologic approach reduces physiologic stress and clinical complications.

Why it matters

Potential benefit: If successful, this approach could reduce postoperative inflammation, lower hyperglycemia and pain, and potentially decrease complications and hospital readmissions after long spinal fusions.

How similar studies have gone: Vagal nerve stimulation has shown promising anti-inflammatory and pain-modulating effects in prior pilot and non-surgical studies, but its use specifically to improve outcomes after long-segment spinal fusion is novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Long-segment spinal fusions (defined as constructs spanning at least L2-pelvis for thoracolumbar fusions or C2-T2 for cervical fusions)
* Ability to undergo a reliable neurologic examination and pain assessments

Exclusion Criteria:

* Patients \<18 years of age
* Shorter-segment spinal fusions than those described above
* Undergoing current active cancer therapy
* Undergoing treatment with immunosuppressive drugs
* Additional spinal surgery within past 6 months
* Sustained bradycardia or presence of pacemaker
* History of substance abuse

Where it's running

  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.